Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

386
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
386
Crossover Experiments01:16

Crossover Experiments

4.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.7K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

368
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
368
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

460
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
460
Clinical Trials01:16

Clinical Trials

11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semiparametric Panel Count Model, With Applications to Signal Detection in Post-Market Drug Surveillance Systems.

Statistics in medicine·2026
Same author

Redox-regulated in situ-forming hydrogel informed by single-cell transcriptomics for functional restoration of injured vocal folds.

Nature communications·2026
Same author

Trajectories and Influencing Factors of Depression in Patients with H-Type Hypertension-Related Ischemic Stroke: A Single-Center Longitudinal Study.

Patient preference and adherence·2026
Same author

NUDT21 Downregulation Promotes Liver Fibrosis by Activating the PIM2-Mediated CEBPB/SLC2A1 Glycolytic Axis in Hepatic Stellate Cells.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Predictive Analyses of Tumor Relapse-free Survival Prognosis Related to Consistency between Different Cancer Tissues and Adjacent Normal Tissues in Drug Repurposing for Solid Tumor via Connectivity Map.

Current medicinal chemistry·2026
Same author

Generative AI-assisted Bayesian-frequentist Hybrid Inference in Single-cell RNA Sequencing Analysis for Genes Associated with Alzheimer's Disease.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Mar 28, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K

Adaptive Design for Staggered-Start Clinical Trial.

Ao Yuan, Qizhai Li, Ming Xiong

    The International Journal of Biostatistics
    |December 15, 2015
    PubMed
    Summary

    This study introduces adaptive designs for staggered-start clinical trials, showing optimality can be maintained if initial patient groups are small. This ensures efficient treatment allocation in trials where treatments begin at different times.

    More Related Videos

    Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
    08:58

    Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

    Published on: October 17, 2025

    808
    A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
    04:24

    A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

    Published on: April 19, 2019

    12.9K

    Related Experiment Videos

    Last Updated: Mar 28, 2026

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
    04:53

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

    Published on: September 20, 2019

    11.5K
    Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
    08:58

    Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

    Published on: October 17, 2025

    808
    A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
    04:24

    A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

    Published on: April 19, 2019

    12.9K

    Area of Science:

    • Clinical trial design
    • Biostatistics
    • Adaptive clinical trials

    Background:

    • Optimizing treatment allocation in clinical trials is crucial for patient safety and study efficiency.
    • Traditional clinical trials assume simultaneous treatment introduction, which may not reflect real-world scenarios.
    • Staggered-start clinical trials, where treatments begin sequentially, present unique challenges for maintaining allocation optimality.

    Purpose of the Study:

    • To develop and evaluate adaptive designs for staggered-start clinical trials.
    • To determine conditions under which allocation optimality can be preserved in staggered-start designs.
    • To provide methods for allocating patients to treatments to achieve desired optimality criteria.

    Main Methods:

    • Proposed a class of adaptive designs for staggered-start clinical trials.
    • Analyzed the asymptotic properties of allocation proportions under the proposed designs.
    • Investigated the impact of initial sample sizes on achieving full optimality.
    • Illustrated the method with examples and a simulation study.

    Main Results:

    • The proposed adaptive designs can achieve asymptotic optimality for allocation proportions in staggered-start trials.
    • Optimality is maintained provided that initial sample sizes are not excessively large relative to the total sample size.
    • Full optimality is compromised if initial sample sizes are of similar magnitude to the total sample size.

    Conclusions:

    • Adaptive designs offer a viable approach to maintaining allocation optimality in staggered-start clinical trials.
    • The effectiveness of these designs is dependent on the relative size of initial patient cohorts.
    • The proposed methods are practical and applicable to various optimality criteria.